Apoptosis and the response to anticancer therapy

被引:82
|
作者
Mow, BMF
Blajeski, AL
Chandra, J
Kaufmann, SH
机构
[1] Mayo Clin & Mayo Fdn, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Mol Pharmacol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Div Oncol Res, Rochester, MN 55905 USA
关键词
D O I
10.1097/00001622-200111000-00007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Apoptosis is a distinctive form of cell death that reflects cleavage of a subset of intracellular polypeptides by proteases known as caspases. Two major intracellular caspase cascades, one activated predominately by death receptor ligands and the other triggered by various cellular stresses, including DNA damage and microtubule disruption, have been delineated. Activation of these protease cascades is tightly regulated by a number of polypeptides, including Bcl-2 family members, inhibitor of apoptosis proteins, and several protein kinases. The demonstration that many antineoplastic agents induce apoptosis in susceptible cells raises the possibility that factors affecting caspase activation and activity might be important determinants of anticancer drug sensitivity. Here, we review recent studies describing the regulation of apoptotic pathways and identify potential implications of these findings for resistance to antineoplastic agents. Curr Opin Oncol 2001, 13:453-462 (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:453 / 462
页数:10
相关论文
共 50 条
  • [41] A fractal dimension analysis: A new method for evaluating the response of anticancer therapy
    Omori, H
    Nio, Y
    Yano, S
    Itakura, M
    Koike, M
    Toga, T
    Matsuura, S
    ANTICANCER RESEARCH, 2002, 22 (04) : 2347 - 2354
  • [42] Unfolded protein response to autophagy as a promising druggable target for anticancer therapy
    Suh, Dong Hoon
    Kim, Mi-Kyung
    Kim, Hee Seung
    Chung, Hyun Hoon
    Song, Yong Sang
    NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER, 2012, 1271 : 20 - 32
  • [43] The use of tumour volumetrics to assess response to therapy in anticancer clinical trials
    Goldmacher, Gregory V.
    Conklin, James
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (06) : 846 - 854
  • [44] Transforming growth factor-β and the immune response:: Implications for anticancer therapy
    Wrzesinski, Stephen H.
    Wan, Yisong Y.
    Flavell, Richard A.
    CLINICAL CANCER RESEARCH, 2007, 13 (18) : 5262 - 5270
  • [45] Switching Apoptosis to Ferroptosis: Metal-Organic Network for High-Efficiency Anticancer Therapy
    Zheng, Di-Wei
    Lei, Qi
    Zhu, Jing-Yi
    Fan, Jin-Xuan
    Li, Chu-Xin
    Li, Cao
    Xu, Zushun
    Cheng, Si-Xue
    Zhang, Xian-Zheng
    NANO LETTERS, 2017, 17 (01) : 284 - 291
  • [46] Piezoelectric enhanced sulfur doped graphdiyne nanozymes for synergistic ferroptosis-apoptosis anticancer therapy
    Wang, Jianxin
    Chu, Yinzhu
    Zhao, Zhiyu
    Zhang, Cong
    Chen, Qi
    Ran, Haitao
    Cao, Yang
    Wu, Changjun
    JOURNAL OF NANOBIOTECHNOLOGY, 2023, 21 (01)
  • [47] Low frequency ultrasound detection of apoptosis in response to cancer therapy
    Ranieri, S.
    Azrif, M.
    Debeljevic, B.
    Papanicolau, M.
    Giles, A.
    Kolios, M.
    Czarnota, G.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S84 - S84
  • [48] Evaluation of apoptosis regulatory proteins in response to PUVA therapy for psoriasis
    El-Domyati, Moetaz
    Moftah, Noha H.
    Nasif, Ghada A.
    Abdel-Wahab, Hossam M.
    Barakat, Manal T.
    Abdel-Aziz, Rasha T.
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2013, 29 (01) : 18 - 26
  • [49] Apoptosis of tumor cells in response to boron neutron capture therapy
    Yamamoto, T
    Matsumura, A
    Shibata, Y
    Yoshida, F
    Nakai, K
    Nose, T
    Horiguchi, Y
    Aizawa, M
    Nakajima, S
    Sakata, I
    FRONTIERS IN NEUTRON CAPTURE THERAPY, VOLS 1 AND 2, 2001, : 1293 - 1297
  • [50] Activation of apoptosis pathways by anticancer treatment
    Debatin, KM
    TOXICOLOGY LETTERS, 2000, 112 : 41 - 48